Read the Beforeitsnews.com story here. Advertise at Before It's News here.

By Alton Parrish (Reporter)
Contributor profile | More stories

Story Views
Now:
Last hour:
Last 24 hours:
Total:

New Dual-Targeting Nanoparticles Lower Cancer’s Defenses and Attack Tumors

Friday, June 23, 2017 9:36

% of readers think this story is Fact. Add your two cents.

Cancer immunotherapy has emerged as one of the most exciting directions in cancer treatment. But the approach only works in a fraction of patients and can cause nasty side effects.

Now, in the journal ACS Nano, scientists report the development of the first dual-cell targeting immunotherapy nanoparticle that slows tumor growth in mice with different cancers. In their study, up to half the mice in one cancer group went into full remission after the treatment.

Immunotherapy works by giving the body’s own immune system a boost in its fight against disease. In cancer patients, there are two main lines of immunotherapy: One disables cancer cells’ ability to hide from the immune system, and the other recruits the body’s T cells to destroy tumors. Jonathan P. Schneck and colleagues wanted to see if they could combine these two tactics with one nanoparticle-based platform.

A two-in-one approach to immunotherapy involves both blocking cancer cells’ (red) ability to hide and prompting T cells (gray) to attack them.

Credit: Andrea Danti/Shutterstock.com

To incorporate these two functions into one system, the researchers developed “immunoswitch” nanoparticles. They’re designed to simultaneously turn off a pathway on tumor cells that would otherwise be used to become invisible to the immune system, and turn on a specific T cell process that launches them into action against cancer cells.

Testing on mouse models of melanoma and colon cancer showed that animals injected with the nanoparticles lived longer than those that did not receive the nanoparticles, and their tumor growth was delayed or even reversed in some cases. That the nanoparticles were effective against two different cancers suggests that they could help treat a variety of tumor types.

Further analysis found that the platform created a synergistic effect, which researchers say allowed them to use low treatment concentrations to potentially reduce the severe side effects that dual immunotherapy is known for.

The authors acknowledge funding from the National Science Foundation, the Center of Cancer Nanotechnology Excellence at the Johns Hopkins Institute, the National Cancer Institute, the National Institutes of Health, the TEDCO/Maryland Innovation Initiative and the Wallace H. Coulter Foundation.]

Contacts and sources:

American Chemical Society

Citation: “Dual Targeting Nanoparticle Stimulates the Immune System to Inhibit Tumor Growth“ ACS Nano

Source:

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!

Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST

Order by Phone at 866-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST

Order by Phone at 866-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST

Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation.

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)

Oxy Powder - Natural Colon Cleanser! Cleans out toxic buildup with oxygen!

Nascent Iodine - Promotes detoxification, mental focus and thyroid health.

Smart Meter Cover - Reduces Smart Meter radiation by 96%! (See Video).

Comments

Online:
Visits:	1,599,840,424
Stories:	8,140,391